1. Higher incidence of acute respiratory distress syndrome (ARDS) and mortality rate among subjects with higher levels of plasma tissue inhibitor of matrix metalloproteinase-3 (TIMP-3) levels.
Higher incidence of acute respiratory distress syndrome (ARDS) and mortality rate among subjects with higher levels of plasma tissue inhibitor of matrix metalloproteinase-3 (TIMP-3) levels. There is a significant trend of ARDS incidence and mortality rates across increasing quartiles of TIMP-3. The results of non-parametric tests for trend across ordered groups are indicated by the p values. ED, emergency department.
Carolyn M Hendrickson et al. Trauma Surg Acute Care Open 2018;3:e000171
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) All rights reserved. No commercial use is permitted unless otherwise expressly granted.